MTech Acquisition Corp. Amends Merger Agreement
by Kristi Marvin on 2019-04-19 at 8:41am

If only tomorrow wasn’t Saturday…MTech could have filed this on 4/20*…

If you’ve been wondering what’s been going on with MTech, well…we have an answer.  Sort of. Mtech Acquisition Corp. (MTEC) was supposed to hold their shareholder vote to complete their business combination with MJ Freeway, back on March 12th.  However, since then, there’s been a real lack of information.  Nothing has been announced or filed relating to what happened to the vote or if it had even been rescheduled. Nonetheless, MTech did finally file an 8-K and proxy/S-4 this morning announcing a few changes to to its merger agreement.  In summary, the changes are:

  • an increase of the size of the Pubco board of directors from seven (7) to eight (8) directors,
  • an increase of the number of directors appointed by MJF from four (4) to five (5) directors (which additional director will qualify as an independent director under Nasdaq rules) and,
  • a revision of the classification of directors so that the Class B directors will include two (2) MJF directors and one (1) MTech director.

However, there was still no mention of what happened with the previous vote, but we can surmise that there needed to be additional negotiations with MJ Freeway.  The final result is that the consideration appears to be the same, it’s just some tweaks to the board composition.

A new vote date has still not been rescheduled, but now that we have some documents filed it looks like this combination is back on track.

* If you didn’t catch the 420 reference, you can find an explanation here

 

Recent Posts
by Nicholas Alan Clayton on 2024-04-16 at 11:33am

Overall deal flow between SPACs and biotech firms has slowed over the last year, but some pending FDA changes could breathe new life into particular business models within the space. In particular, the FDA has asked Congress as part of its 2025 Legislative Proposals to eliminate the interchangeability designation for biosimilar medications, claiming the existing...

by Nicholas Alan Clayton on 2024-04-16 at 7:58am

At the SPAC of Dawn Ever since Digital World announced its combination with Trump Media (NASDAQ:DJT) back in October 2021, it was clear that SPACworld and the Trump show were set to be intertwined for quite some time. And, although not every headline has a bearing on the wider SPAC world, Trump Media’s post-close rise...

by Nicholas Alan Clayton on 2024-04-15 at 3:47pm

AltC (NYSE:ALCC) has reportedly been taking the pitch deck for its combination with nuclear fission firm Oklo on the road in recent weeks, which has generated the rare result of a SPAC trading significantly above its trust value still well before completing its deal. The SPAC has an estimated $10.59 per share in its trust...

by Nicholas Alan Clayton on 2024-04-15 at 9:35am

Trump Media (NASDAQ:DJT) is down about -15% in the pre-market following the filing of its first S-1 since closing its combination with Digital World, and this includes the issuance of the 21,491,251 shares. Of these, 14,375,000 are to be made available for those exercising warrants while the rest would go out to note holders from...

by Nicholas Alan Clayton on 2024-04-15 at 7:44am

At the SPAC of Dawn This week, bookended by the end of Ramadan and the beginning of Passover, could wind up stacked with events to avoid those holiday times, but for now SPACs have scheduled just six extension votes for this stretch. Redwood (NASDAQ:RWOD) and Genesis Growth Tech (OTC:GGAAF) have yet to release results from...

logo

Copyright © 2023 SPACInsider, Inc. All Rights Reserved